Join today and have your say! It’s FREE!

We will not release or resell your information to third parties without your permission.

Please Try Again

{{ error }}

By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Please Try Again

{{ error }}

Password Hint : {{passwordHint}}

Remember me

Forgot Password?

or

Privacy Policy | Disclaimer

Quote | Bullboard | News | Opinion | Profile | Peers | Filings | Financials | Options | Price History | Ratios | Ownership | Insiders | Valuation

Breaking & Recent News Sanofi Ord Shs SNYNF

Healthcare

Sanofi SA is a France-based healthcare company based in France. The Company focuses on patient needs and engages in the research, development, manufacture, and marketing of therapeutic solutions. Its three operating segments are: Pharmaceuticals, Consumer Healthcare (CHC), and Vaccines. The Pharmaceuticals includes: Immunology, Multiple Sclerosis / Neurology, Oncology, Rare Diseases, Rare Blood... see more

Add To Watchlist

Recent & Breaking News (OTCPK:SNYNF)

Technical Briefing on SNY, VVUS, ACUR, and NSPH

Accesswire April 29, 2013

Once-daily AUBAGIO® Delayed Onset of Clinically Definite Multiple Sclerosis (MS) in TOPIC Study

Business Wire April 25, 2013

U.S. FDA Grants Fast-Track Designation to Sanofi Pasteur and KaloBios' Novel Biologic Candidate for Pseudomonas aeruginosa

PR Newswire April 23, 2013

Genzyme Convenes 13th European Fabry Disease Roundtable

Business Wire April 18, 2013

New Allegra® Anti-Itch Cream Introduced by Sanofi's Chattem

PR Newswire April 11, 2013

Genzyme's Once-daily, Oral AUBAGIO® (teriflunomide) Approved in Argentina for the Treatment of Relapsing Multiple Sclerosis

Business Wire April 8, 2013

Basketball Legend Lisa Leslie Teams Up with Allegra® to Help Families Enjoy Outdoor Workouts This Allergy Season

PR Newswire March 28, 2013

Morning Research on Sanofi, Keryx Biopharma, VIVUS, and Array BioPharma

PR Newswire March 27, 2013

The Reason It Trades, What's Moving SNY, SPLS, RF and NBG

Marketwired March 26, 2013

Genzyme Receives Positive CHMP Opinion in the European Union for Once-daily, Oral AUBAGIO® to Treat Relapsing-Remitting Multiple Sclerosis

Business Wire March 22, 2013

Effect of Genzyme's LEMTRADA(TM) Maintained in Patients Beyond Two-Year Pivotal MS Studies

Business Wire March 21, 2013

Sanofi US Offers a New Way to Say "Thank You" and Recognize the Unsung Heroes of Severe Allergy Awareness

PR Newswire March 14, 2013

Genzyme's Multiple Sclerosis Franchise Featured at AAN

Business Wire March 13, 2013

Perfect Trade Setups, How to Play APC, KMB, MCK and SNY

Marketwired March 12, 2013

Sanofi Oncology and Colon Cancer Coalition Join Forces to Raise Awareness of Colorectal Cancer

PR Newswire March 6, 2013

Genzyme's Head of Rare Diseases Honored by the Genetic Disease Foundation

Business Wire March 4, 2013

Sanofi and Regeneron Report Positive Proof-of-Concept Data for Dupilumab, an IL-4R alpha Antibody, in Atopic Dermatitis

PR Newswire March 2, 2013

Genzyme Recognizes International Rare Disease Day with Global Awareness Programs and Launch of Third Annual Patient Advocacy Leadership (PAL) Awards

Business Wire February 28, 2013

The Real Story Behind ESRX, SNY, CMCSA and GM

Marketwired February 27, 2013

Genzyme Receives Company Award from European Organisation for Rare Diseases (EURORDIS)

Business Wire February 27, 2013